Table 3 Independent predictors for PPM implantation after CTI-dependent AFL ablation.
Variable | Univariate analysis | Multivariate analysis* | ||
|---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | |
Age | 1.023 (0.993–1.054) | 0.133 | ||
Female sex | 4.046 (1.922–8.516) | < 0.001 | 2.929 (0.890–9.646) | 0.077 |
Body mass index, per 1 kg/m2 increase | 0.896 (0.787–1.020) | 0.098 | 0.879 (0.694–1.113) | 0.284 |
Diabetes mellitus | 0.924 (0.397–2.154) | 0.855 | ||
Hypertension | 1.430 (0.655–3.122) | 0.370 | ||
Chronic kidney disease | 2.834 (1.073–7.488) | 0.036 | 2.070 (0.308–13.927) | 0.454 |
Heart failure | 0.920 (0.408–2.073) | 0.840 | ||
Previous stroke | 3.656 (1.492–8.959) | 0.005 | 1.718 (0.223–13.229) | 0.604 |
Prior atrial fibrillation | 2.200 (1.054–4.592) | 0.036 | 3.570 (1.034–12.325) | 0.044 |
Persistent AFL | 1.587 (0.648–3.888) | 0.412 | ||
CHA2DS2-VASc score, per 1 score increase | 1.399 (1.129–1.733) | 0.003 | 0.942 (0.599–1.481) | 0.797 |
The lowest previous sinus heart rate, per 1 beats/minute increase | 0.923 (0.891–0.957) | < 0.001 | 0.942 (0.898–0.988) | 0.015 |
The lowest previous AFL heart rate, per 1 beats/minute increase | 0.981 (0.968–0.995) | 0.008 | 0.999 (0.978–1.020) | 0.898 |
Previous sinus pause over 3 s | 10.900 (2.568–46.300) | 0.001 | 2.937 (0.326–26.468) | 0.337 |
PR interval, per 1 ms increase | 1.011 (1.001–1.022) | 0.025 | 1.006 (0.992–1.020) | 0.434 |
QRS duration | 1.012 (0.996–1.029) | 0.148 | ||
Right bundle branch block | 1.227 (0.372–4.049) | 0.856 | ||
Left bundle branch block | 4.858 (1.459–16.170) | 0.010 | 0.465 (0.051–4.261) | 0.498 |
LA volume index, per 1 ml/m2 increase | 1.058 (1.035–1.082) | < 0.001 | 1.067 (1.024–1.112) | 0.002 |
LV ejection fraction | 1.004 (0.974–1.035) | 0.805 | ||
E/e’ | 1.035 (1.002–1.070) | 0.038 | 0.946 (0.857–1.043) | 0.261 |
RV systolic pressure | 1.025 (0.992–1.058) | 0.140 | ||
Type of antiarrhythmic agent used after ablation | 1.011 (0.594–1.722) | 0.967 | ||